Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19845474 | 0.97 | KDM4E (0.41) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845481 | 0.97 | KDM4E (0.41) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845442 | 0.97 | KDM4E (0.41) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL22672217 | 0.96 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845489 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845540 | 0.95 | KDM4E (0.39) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL22751065 | 0.95 | KDM4E (0.41) | KDM4EATML3MBTL1PTGER4KMT2A | |
| SCHEMBL19845465 | 0.93 | KDM4E (0.44) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845439 | 0.93 | KDM4E (0.44) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845451 | 0.92 | L3MBTL1 (0.41) | KDM4EATML3MBTL1PTGER4PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, ETV6, LEF1 | KDM4E 2538/4885ATM 3035/4885L3MBTL1 3274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.